These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 35953476)
21. The AMPK agonist AICAR inhibits the growth of EGFRvIII-expressing glioblastomas by inhibiting lipogenesis. Guo D; Hildebrandt IJ; Prins RM; Soto H; Mazzotta MM; Dang J; Czernin J; Shyy JY; Watson AD; Phelps M; Radu CG; Cloughesy TF; Mischel PS Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12932-7. PubMed ID: 19625624 [TBL] [Abstract][Full Text] [Related]
22. PTEN augments SPARC suppression of proliferation and inhibits SPARC-induced migration by suppressing SHC-RAF-ERK and AKT signaling. Thomas SL; Alam R; Lemke N; Schultz LR; Gutiérrez JA; Rempel SA Neuro Oncol; 2010 Sep; 12(9):941-55. PubMed ID: 20472716 [TBL] [Abstract][Full Text] [Related]
23. PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion. Mense SM; Barrows D; Hodakoski C; Steinbach N; Schoenfeld D; Su W; Hopkins BD; Su T; Fine B; Hibshoosh H; Parsons R Sci Signal; 2015 Mar; 8(370):ra32. PubMed ID: 25829446 [TBL] [Abstract][Full Text] [Related]
24. TOPK/PBK promotes cell migration via modulation of the PI3K/PTEN/AKT pathway and is associated with poor prognosis in lung cancer. Shih MC; Chen JY; Wu YC; Jan YH; Yang BM; Lu PJ; Cheng HC; Huang MS; Yang CJ; Hsiao M; Lai JM Oncogene; 2012 May; 31(19):2389-400. PubMed ID: 21996732 [TBL] [Abstract][Full Text] [Related]
25. miR-494-3p Regulates Cellular Proliferation, Invasion, Migration, and Apoptosis by PTEN/AKT Signaling in Human Glioblastoma Cells. Li XT; Wang HZ; Wu ZW; Yang TQ; Zhao ZH; Chen GL; Xie XS; Li B; Wei YX; Huang YL; Zhou YX; Du ZW Cell Mol Neurobiol; 2015 Jul; 35(5):679-87. PubMed ID: 25662849 [TBL] [Abstract][Full Text] [Related]
26. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Meng F; Henson R; Wehbe-Janek H; Ghoshal K; Jacob ST; Patel T Gastroenterology; 2007 Aug; 133(2):647-58. PubMed ID: 17681183 [TBL] [Abstract][Full Text] [Related]
27. The p17 nonstructural protein of avian reovirus triggers autophagy enhancing virus replication via activation of phosphatase and tensin deleted on chromosome 10 (PTEN) and AMP-activated protein kinase (AMPK), as well as dsRNA-dependent protein kinase (PKR)/eIF2α signaling pathways. Chi PI; Huang WR; Lai IH; Cheng CY; Liu HJ J Biol Chem; 2013 Feb; 288(5):3571-84. PubMed ID: 23233667 [TBL] [Abstract][Full Text] [Related]
28. Mammalian target of rapamycin inhibition promotes response to epidermal growth factor receptor kinase inhibitors in PTEN-deficient and PTEN-intact glioblastoma cells. Wang MY; Lu KV; Zhu S; Dia EQ; Vivanco I; Shackleford GM; Cavenee WK; Mellinghoff IK; Cloughesy TF; Sawyers CL; Mischel PS Cancer Res; 2006 Aug; 66(16):7864-9. PubMed ID: 16912159 [TBL] [Abstract][Full Text] [Related]
29. PTEN loss represses glioblastoma tumor initiating cell differentiation via inactivation of Lgl1. Gont A; Hanson JE; Lavictoire SJ; Parolin DA; Daneshmand M; Restall IJ; Soucie M; Nicholas G; Woulfe J; Kassam A; Da Silva VF; Lorimer IA Oncotarget; 2013 Aug; 4(8):1266-79. PubMed ID: 23907540 [TBL] [Abstract][Full Text] [Related]
30. Aurora-A-mediated phosphorylation of LKB1 compromises LKB1/AMPK signaling axis to facilitate NSCLC growth and migration. Zheng X; Chi J; Zhi J; Zhang H; Yue D; Zhao J; Li D; Li Y; Gao M; Guo J Oncogene; 2018 Jan; 37(4):502-511. PubMed ID: 28967900 [TBL] [Abstract][Full Text] [Related]
31. Loss of PTEN binding adapter protein NHERF1 from plasma membrane in glioblastoma contributes to PTEN inactivation. Molina JR; Morales FC; Hayashi Y; Aldape KD; Georgescu MM Cancer Res; 2010 Sep; 70(17):6697-703. PubMed ID: 20736378 [TBL] [Abstract][Full Text] [Related]
32. PTEN inhibits the migration and invasion of HepG2 cells by coordinately decreasing MMP expression via the PI3K/Akt pathway. Tian T; Nan KJ; Guo H; Wang WJ; Ruan ZP; Wang SH; Liang X; Lu CX Oncol Rep; 2010 Jun; 23(6):1593-600. PubMed ID: 20428814 [TBL] [Abstract][Full Text] [Related]
33. Differential role of PTEN in transforming growth factor β (TGF-β) effects on proliferation and migration in prostate cancer cells. Kimbrough-Allah MN; Millena AC; Khan SA Prostate; 2018 Apr; 78(5):377-389. PubMed ID: 29341212 [TBL] [Abstract][Full Text] [Related]
34. KAP regulates ROCK2 and Cdk2 in an RNA-activated glioblastoma invasion pathway. Li H; Jiang X; Yu Y; Huang W; Xing H; Agar NY; Yang HW; Yang B; Carroll RS; Johnson MD Oncogene; 2015 Mar; 34(11):1432-41. PubMed ID: 24704824 [TBL] [Abstract][Full Text] [Related]
35. Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances breast cancer cell migration. Heering J; Erlmann P; Olayioye MA Exp Cell Res; 2009 Sep; 315(15):2505-14. PubMed ID: 19482022 [TBL] [Abstract][Full Text] [Related]
36. Phosphatase and tensin homolog reconstruction and vascular endothelial growth factor knockdown synergistically inhibit the growth of glioblastoma. Chen H; Shen X; Guo C; Zhu H; Zhou L; Zhu Y; Wang H; Zheng Y; Huang L Cancer Biother Radiopharm; 2010 Dec; 25(6):713-21. PubMed ID: 21204766 [TBL] [Abstract][Full Text] [Related]
37. LKB1 is required for adiponectin-mediated modulation of AMPK-S6K axis and inhibition of migration and invasion of breast cancer cells. Taliaferro-Smith L; Nagalingam A; Zhong D; Zhou W; Saxena NK; Sharma D Oncogene; 2009 Jul; 28(29):2621-33. PubMed ID: 19483724 [TBL] [Abstract][Full Text] [Related]
38. PTEN inhibition attenuates endothelial cell apoptosis in coronary heart disease via modulating the AMPK-CREB-Mfn2-mitophagy signaling pathway. Li P; Wang J; Zhao X; Ru J; Tian T; An Y; Tang L; Bai Y J Cell Physiol; 2020 May; 235(5):4878-4889. PubMed ID: 31654396 [TBL] [Abstract][Full Text] [Related]
39. PTEN is destabilized by phosphorylation on Thr366. Maccario H; Perera NM; Davidson L; Downes CP; Leslie NR Biochem J; 2007 Aug; 405(3):439-44. PubMed ID: 17444818 [TBL] [Abstract][Full Text] [Related]
40. Loss of phosphatase and tensin homologue increases transforming growth factor beta-mediated invasion with enhanced SMAD3 transcriptional activity. Hjelmeland AB; Hjelmeland MD; Shi Q; Hart JL; Bigner DD; Wang XF; Kontos CD; Rich JN Cancer Res; 2005 Dec; 65(24):11276-81. PubMed ID: 16357132 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]